WuXi Biologics, Vertex Sign License for T-cell Engager
WuXi Biologics (2269. HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that it has signed a license and research service...
Tag : Vertex Pharmaceuticals
Vertex Announces CASGEVY® Reimbursement for SCD in England
– Agreement means eligible sickle cell disease (SCD) patients in England now have access to CASGEVY – – Agreement for CASGEVY in transfusion-dependent beta thalassemia...